• Deutsch (DE-CH-AT)
  • English (United Kingdom)

NOTICE

with regard to the manufacturing license:
TICEBA
possesses the required authorization by the competent authority for the manufacturing of tissue as source material of human origin for the manufacturing of pharmaceuticals in accordance with § 20 b and § 20 c of the German Medicines Act: Authorization for the treatment or processing, preservation, storage of tissue or tissue preparations.

Staff and management


Our staff is TICEBA's greatest asset. Only with a strong team we are able to realize our high requirements and master upcoming challenges. We therefore look after the wellbeing of our staff.


Management

"I am fascinated by the current treatments and the treatments to be expected from the synthesis of the research of adult stem cells and tissue engineering. In the near future, we will witness a revolutionary medicine."

dr-ganss TICEBA is lead by the physician and entrepreneur Dr. med. Christoph Ganss. He has several years of experience in surgical fields. Among others, Dr. Ganss has competent knowledge of cardiac and thoracic surgery, vascular surgery and traumatology. He has acquired his well-founded knowledge in medicine and science both in Germany and abroad.



Scientific advisor

"Adult stem cells from the skin open up the fascinating possibility of efficient application in regenerative medicine due to their easy and abounding availability."

dr-frank Dr. med. Markus Frank, Assistant Professor of Harvard Medical School, is assisting TICEBA as scientific advisor. He is physician and basic researcher and teaching as such at the renowned Harvard University in Cambridge/USA and has particular expertise in stem cell research and determination.



Staff

"We are proud to get to play a part in the innovative developments as part of TICEBA and to contribute our knowledge."

ticeba-team-2011

NEWS

TICEBA receives SME eligibility of EMA. continue »
TICEBA now on facebook. continue »
next event:
29. - 31. May 2012, ECOPRAM - European Congress on Preventive, Regenerative and Anti-Aging Medicine, Istanbul (Turkey). Topic: "Autologous pluripotent mesenchymal stem cells from the skin". Booth: 12. continue »

NEWSLETTER

INFORMATIONS

Request any information from us now.

COUNSELLING

"We are glad to counsel you in person", Dr. Christoph Ganss:
+49 (0)6221.718 33 0